🌎 Viking Therapeutics Initiated, Cisco Systems Upgraded, AT&T Upgraded and more…
RJ Hamster
Ratings changes for AppLovin, AppLovin, Robinhood Markets, Robinhood Markets, Viking Therapeutics, Silicon Motion Technology, Beacon Roofing Supply and more…Text “MarketBeat” to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.
Apple Inc. (NASDAQ:AAPL) announced a quarterly dividend on Thursday, January 30th. Shareholders of record on Monday, February 10th will be given a dividend of 0.25 per share by the iPhone maker on Thursday, February 13th. This represents a $1.00 dividend on an annualized basis and a yield of 0.42%. The ex-dividend date of this dividend is Monday, February 10th.
CEO Mark Zuckerberg sold 19,668 shares of the company’s stock in a transaction on Wednesday, February 12th. The shares were sold at an average price of $721.69, for a total value of $14,194,198.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
CEO Mark Zuckerberg sold 35,795 shares of the business’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $715.82, for a total transaction of $25,622,776.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
AstraZeneca (NASDAQ:AZN) was upgraded by analysts at UBS Group AG from a “neutral” rating to a “buy” rating.The current price is $74.72.
Casey’s General Stores (NASDAQ:CASY) was upgraded by analysts at Gordon Haskett from a “hold” rating to a “buy” rating.The current price is $436.91.
Cisco Systems (NASDAQ:CSCO) was upgraded by analysts at Rosenblatt Securities from a “neutral” rating to a “buy” rating. They now have a $80.00 price target on the stock, up previously from $66.00. This represents a 26.0% upside from the current price of $63.47.
CVS Health (NYSE:CVS) was upgraded by analysts at Leerink Partners from a “market perform” rating to an “outperform” rating. They now have a $75.00 price target on the stock, up previously from $55.00. This represents a 14.9% upside from the current price of $65.30.
Cytokinetics (NASDAQ:CYTK) was upgraded by analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating. They now have a $67.00 price target on the stock, down previously from $70.00. This represents a 58.4% upside from the current price of $42.29.
DuPont de Nemours (NYSE:DD) was upgraded by analysts at Barclays PLC from an “underweight” rating to an “equal weight” rating. They now have a $89.00 price target on the stock, up previously from $85.00. This represents a 8.0% upside from the current price of $82.42.
Ecopetrol (NYSE:EC) was upgraded by analysts at JPMorgan Chase & Co. from an “underweight” rating to a “neutral” rating. They now have a $9.50 price target on the stock, up previously from $7.50. This represents a 3.8% downside from the current price of $9.88.
Gilead Sciences (NASDAQ:GILD) was upgraded by analysts at DZ Bank AG from a “hold” rating to a “buy” rating. They now have a $108.00 price target on the stock. This represents a 2.2% upside from the current price of $105.62.
Genmab A/S (NASDAQ:GMAB) was upgraded by analysts at Leerink Partners from a “market perform” rating to an “outperform” rating. They now have a $27.00 price target on the stock. This represents a 32.6% upside from the current price of $20.36.
HubSpot (NYSE:HUBS) was upgraded by analysts at KeyCorp from a “sector weight” rating to an “overweight” rating. They now have a $920.00 price target on the stock. This represents a 8.1% upside from the current price of $850.76.
Jazz Pharmaceuticals (NASDAQ:JAZZ) was upgraded by analysts at Wells Fargo & Company from an “equal weight” rating to an “overweight” rating. They now have a $170.00 price target on the stock, up previously from $130.00. This represents a 23.9% upside from the current price of $137.25.
Coca-Cola (NYSE:KO) was upgraded by analysts at DZ Bank AG from a “hold” rating to a “buy” rating. They now have a $75.00 price target on the stock. This represents a 8.0% upside from the current price of $69.45.
Manhattan Associates (NASDAQ:MANH) was upgraded by analysts at William Blair from a “market perform” rating to an “outperform” rating.The current price is $184.39.
STMicroelectronics (NYSE:STM) was upgraded by analysts at Morgan Stanley from an “underweight” rating to an “equal weight” rating.The current price is $23.77.
AT&T (NYSE:T) was upgraded by analysts at BNP Paribas from a “neutral” rating to an “outperform” rating. They now have a $28.50 price target on the stock. This represents a 12.1% upside from the current price of $25.44.
Vista Energy (NYSE:VIST) was upgraded by analysts at Citigroup Inc. from a “neutral” rating to a “buy” rating. They now have a $66.00 price target on the stock. This represents a 27.7% upside from the current price of $51.68.
Vishay Precision Group (NYSE:VPG) was upgraded by analysts at B. Riley from a “neutral” rating to a “buy” rating. They now have a $28.50 price target on the stock, up previously from $24.50. This represents a 15.1% upside from the current price of $24.77.
Waters (NYSE:WAT) was upgraded by analysts at Scotiabank from a “sector perform” rating to a “sector outperform” rating. They now have a $450.00 price target on the stock. This represents a 19.0% upside from the current price of $378.27.
Starting 2025 Strong: 2 AI Stocks Under $10 You Can’t Miss (ad)
As we step into 2025, artificial intelligence (AI) continues to revolutionize industries with groundbreaking advancements. From the surge in generative AI technologies transforming creative processes to AI-driven automation enhancing operational efficiencies, the landscape is brimming with innovation. These rapid developments are creating lucrative opportunities for investors who recognize the potential of emerging AI companies.
Fluence Energy (NASDAQ:FLNC) was downgraded by analysts at Bank of America Co. from a “buy” rating to a “neutral” rating. They now have a $8.00 price target on the stock, down previously from $20.00. This represents a 25.2% upside from the current price of $6.39.
General Dynamics (NYSE:GD) was downgraded by analysts at BTIG Research from a “buy” rating to a “neutral” rating.The current price is $250.20.
Kraft Heinz (NASDAQ:KHC) was downgraded by analysts at Bank of America Co. from a “buy” rating to an “underperform” rating. They now have a $30.00 price target on the stock, down previously from $36.00. This represents a 5.5% upside from the current price of $28.43.
Kraft Heinz (NASDAQ:KHC) was downgraded by analysts at Citigroup Inc. from a “buy” rating to a “neutral” rating. They now have a $28.00 price target on the stock, down previously from $34.00. This represents a 1.5% downside from the current price of $28.43.
Macy’s (NYSE:M) was downgraded by analysts at Gordon Haskett from a “buy” rating to an “accumulate” rating.The current price is $14.66.
Olin (NYSE:OLN) was downgraded by analysts at Piper Sandler from an “overweight” rating to a “neutral” rating. They now have a $33.00 price target on the stock, down previously from $41.00. This represents a 20.0% upside from the current price of $27.51.
Restaurant Brands International (NYSE:QSR) (TSE:QSR) was downgraded by analysts at Argus from a “buy” rating to a “hold” rating.The current price is $64.64.
Target (NYSE:TGT) was downgraded by analysts at Gordon Haskett from a “buy” rating to a “hold” rating.The current price is $127.44.
Trade Desk (NASDAQ:TTD) was downgraded by analysts at Evercore ISI from an “outperform” rating to an “inline” rating. They now have a $90.00 price target on the stock, down previously from $135.00. This represents a 7.0% upside from the current price of $84.08.
10x Genomics (NASDAQ:TXG) was downgraded by analysts at Leerink Partners from an “outperform” rating to a “market perform” rating. They now have a $12.00 price target on the stock, down previously from $25.00. This represents a 4.9% upside from the current price of $11.44.
Amer Sports (NYSE:AS) is now covered by analysts at Sanford C. Bernstein. They set an “outperform” rating and a $38.00 price target on the stock. This represents a 21.3% upside from the current price of $31.32.
Celldex Therapeutics (NASDAQ:CLDX) is now covered by analysts at UBS Group AG. They set a “buy” rating and a $44.00 price target on the stock. This represents a 88.0% upside from the current price of $23.40.
Fortis (NYSE:FTS) is now covered by analysts at Jefferies Financial Group Inc.. They set a “hold” rating on the stock.The current price is $44.24.
GE Vernova (NYSE:GEV) is now covered by analysts at Robert W. Baird. They set an “outperform” rating and a $448.00 price target on the stock. This represents a 18.9% upside from the current price of $376.64.
GH Research (NASDAQ:GHRS) is now covered by analysts at Cantor Fitzgerald. They set an “overweight” rating and a $14.00 price target on the stock. This represents a 2.2% downside from the current price of $14.31.
Jasper Therapeutics (NASDAQ:JSPR) is now covered by analysts at UBS Group AG. They set a “buy” rating and a $38.00 price target on the stock. This represents a 542.4% upside from the current price of $5.92.
LeMaitre Vascular (NASDAQ:LMAT) is now covered by analysts at Wells Fargo & Company. They set an “equal weight” rating and a $95.00 price target on the stock. This represents a 0.0% downside from the current price of $95.05.
Merus (NASDAQ:MRUS) is now covered by analysts at Piper Sandler. They set an “overweight” rating and a $84.00 price target on the stock. This represents a 108.9% upside from the current price of $40.22.
Sunrise Realty Trust (NASDAQ:SUNS) is now covered by analysts at B. Riley. They set a “buy” rating and a $15.00 price target on the stock. This represents a 29.5% upside from the current price of $11.59.
TriSalus Life Sciences (NASDAQ:TLSI) is now covered by analysts at Lake Street Capital. They set a “buy” rating on the stock.The current price is $5.54.
Viking Therapeutics (NASDAQ:VKTX) is now covered by analysts at Scotiabank. They set a “sector outperform” rating and a $102.00 price target on the stock. This represents a 247.8% upside from the current price of $29.33.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
